Table 3 The association between periostitis and voriconazole by sex.

From: Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA Adverse Event Reporting System Database

 

N

χ2

RRR (95%CI)

PRR (95%CI)

ROR (95%CI)

IC (95%CI)

Male

67

29,713.6

451.4 (327.8, 621.6)

2226.4 (1308.3, 3788.9)

2251.7 (1321.5, 3836.5)

8.8 (8.4, 9.1)

Female

59

45,751.2

790.2 (574.7, 1086.5)

1848.4 (1252.6, 2727.6)

1877.7 (1269.1, 2778.1)

9.6 (9.2, 9.9)

  1. RRR relative reporting ratio, CI confidence interval, PRR proportional reporting ratio, ROR reporting odds ratio, IC information components.
Back to article page